Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 141, Issue 8, 2006, Pages 895-901

  Hopfer, Christian J ^a   Young, Susan E ^b   Purcell, Shaun ^c   Crowley, Thomas J ^a   Stallings, Michael C ^b   Corley, Robin P ^b   Rhee, Soo Hyun ^b   Smolen, Andrew ^b   Krauter, Ken ^b   Hewitt, John K ^b   Ehringer, Marissa A ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adolescence; Cannabis; CNR1; Genetics

Indexed keywords

CANNABIS;

ADOLESCENT; ADULT; ADULTHOOD; ALLELE; ARTICLE; CANNABIS ADDICTION; CLINICAL FEATURE; CNR1 GENE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ADOLESCENT; COLORADO; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; INTERVIEWS; LINKAGE DISEQUILIBRIUM; MALE; MARIJUANA ABUSE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CANNABINOID;

CANNABIS; CANNABIS SATIVA;

EID: 33845449985     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30378     Document Type: Article

References (36)

1. Abecasis GR, Cookson WO. 2000. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 16:182-183.
2. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, 4th edition (DSM-IVTR). Washington, DC: American Psychiatric Association.
3. Anchordoquy HC, McGeary C, Liu L, Krauter KS, Smolen A. 2003. Genotyping of three candidate genes after whole-genome preamplification of DNA collected from buccal cells. Behav Genet 33:73-78.
4. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
5. Chen CY, Anthony JC. 2003. Possible age-associated bias in reporting of clinical features of drug dependence: Epidemiological evidence on adolescent-onset marijuana use. Addiction 98:71-82.
6. Chen J, Marmur R, Pulles A, Paredes W, Gardner EL. 1993. Ventral tegmental microinjection of delta 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: Evidence for local neural action by marijuana's psychoactive ingredient. Brain Res 621:65-70.
7. Chen K, Kandel DB, Davies M. 1997. Relationships between frequency and quantity of marijuana use and last year proxy dependence among adolescents and adults in the United States. Drug Alcohol Depend 46:53-67.
8. Childers SR, Breivogel CS. 1998. Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend 51:173-187.
9. Comings DE, Muhleman D, Gade R, Johnson P, Verde R, Saucier G, MacMurray J. 1997. Cannabinoid receptor gene (CNR1): Association with i.v. drug use. Mol Psychiatry 2:161-168.
10. Cottler LB, Robins LN, Heizer JE. 1989. The reliability of the CIDI-SAM: A comprehensive substance abuse interview. Br J Addict 84:801-814.
11. Covault J, Gelernter J, Kranzler H. 2001. Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence. Mol Psychiatry 6:501-502.
12. Crowley TJ, Mikulich SK, Ehlers KM, Whitmore EA, MacDonald MJ. 2001. Validity of structured clinical evaluations in adolescents with conduct and substance problems. J Am Acad Child Adolesc Psychiatry 40:265-273.
13. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. 2002. The structure of haplotype blocks in the human genome. Science 296:2225-2229.
14. Gibbs RA, Belmont JW, Hardenbol P, Willis TD, Yu F, Yang H, et al. 2003. The International HapMap Project. Nature 426:789-796.
15. Hartman C, Gelhorn H, Sakai J, Stallings MC, Young S, Rhee SH, Corley R, Hewitt JK, Crowley TJ, Hopfer CJ. 2006. An Item Response Theory Analysis of DSM-IV marijuana abuse and dependence criteria in an adolescent sample. Abstract, College of Problems on Drug Dependence (In Press).
16. Hoehe MR, Rinn T, Flachmeier C, Heere P, Kunert HJ, Timmermann B, Kopke K, Ehrenreich H. 2000. Comparative sequencing of the human CB1 cannabinoid receptor gene coding exon: No structural mutations in individuals exhibiting extreme responses to cannabis. Psychiatr Genet 10:173-177.
17. Johnson JP, Muhleman D, MacMurray J, Gade R, Verde R, Ask M, Kelley J, Comings DE. 1997. Association between the cannabinoid receptor gene (CNR1) and the P300 event-related potential. Mol Psychiatry 2:169-171.
18. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. 2005. Monitoring the Future national results on adolescent drug use: Overview of key findings, 2004 (NIH Publication No. 05-5726). National Institute on Drug Abuse, Bethesda, MD.
19. Kendler KS, Prescott CA. 1998. Cannabis use, abuse, and dependence in a population-based sample of female twins. Am J Psychiatry 155:1016-1022.
20. Kendler KS, Karkowski LM, Neale MC, Prescott CA. 2000. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 57:261-269.
21. Kendler KS, Jacobson KC, Prescott CA, Neale MC. 2003. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 160:687-695.
22. Li T, Lie X, Zhu ZH, Zhao J, Hu X, Ball DM, Sham PC, Collier DA. 2000. No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population. Mol Psychiatry 5:128-130.
23. Lynskey MT, Heath AC, Nelson EC, Bucholz KK, Madden PA, Slutske WS, Statham DJ, Martin NG. 2002. Genetic and environmental contributions to cannabis dependence in a national young adult twin sample. Psychol Med 32:195-207.
24. Maes HH, Woodard CE, Murrelle L, Meyer JM, Silberg JL, Hewitt JK, Rutter M, Simonoff E, Pickles A, Carbonneau R, Neale MC, Eaves LJ. 1999. Tobacco, alcohol and drug use in eight- to sixteen-year-old twins: The Virginia Twin Study of Adolescent Behavioral Development. J Stud Alcohol 60:293-305.
25. Miles DR, van den Bree MB, Gupman AE, Newlin DB, Glantz MD, Pickens RW. 2001. A twin study on sensation seeking, risk taking behavior and marijuana use. Drug Alcohol Depend 62:57-68.
26. Navarro M, Carrera MR, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, del Arco I, Villanua MA, Maldonado E, Koob GF, Rodriguez de Fonseca F. 2001. Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci 21:5344-5350.
27. Onaivi ES, Leonard CM, Ishiguro H, Zhang PW, Lin Z, Akinshola BE, Uhl GR. 2002. Endocannabinoids and cannabinoid receptor genetics. Prog Neurobiol 66:307-344.
28. Rhee SH, Hewitt JK, Young SE, Corley RP, Crowley TJ, Stallings MC. 2003. Genetic and environmental influences on substance initiation, use, and problem use in adolescents. Arch Gen Psychiatry 60:1256-1264.
29. SAMHSA. 2002. Marijuana Treatment Admissions Increase: 1993-1999. SAMHSA. 4. Substance Abuse and Mental Health Services Administration. 2002. http://www.samhsa.gov/oas/2k2/MJtx.htm
30. Schmidt LG, Samochowiec J, Finckh U, Fiszer-Piosik E, Horodnicki J, Wendel B, Rommelspacher H, Hoehe MR. 2002. Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend 65:221-224.
31. Stephens M, Donnelly P. 2003. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169.
32. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
33. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, True W, Lin N, Toomey R, Eaves L. 1998. Co-occurrence of abuse of different drugs in men: The role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 55:967-972.
34. Young SE, Rhee SH, Stallings MC, Corley RP, Hewitt JK. 2006. Genetic and environmental vulnerabilities underlying adolescent substance use and problem use: General or specific? Behavior Genetics 36:603-615.
35. Zhang PW, Ishiguro H, Ohtsuki T, Hess J, Carillo F, Walther D, Onaivi ES, Arinami T, Uhl GR. 2004. Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry 9:916-931.
36. Zheng S, Ma X, Buffler PA, Smith MT, Wiencke JK. 2001. Whole genome amplification increases the efficiency and validity of buccal cell genotyping in pediatric populations. Cancer Epidemiol Biomarkers Prev 10:697-700.